Delayed Prostate Cancer Therapy Penfield NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Laurie J Milner
(585) 275-7787
601 Elmwood Ave
Rochester, NY
SCOTT BARRETT, MD
(585) 475-8700
211 White Spruce Boulevard
Rochester, NY
JULIA SMITH, MD
(585) 922-4247
1425 Portland Avenue
Rochester, NY
Zachary B Kramer, MD
585-922-4020
1425 Portland Ave
Rochester, NY
Naeem Tahi, MD
585-275-4797
601 Elmwood Ave # 704
Rochester, NY
Pradyumna Phatak
(585) 922-4247
1425 Portland Ave
Rochester, NY
Alan Katz
(585) 275-2171
601 Elmwood Ave # 647
Rochester, NY
ALEXANDER SOLKY, MD
(585) 475-8728
211 White Spruce Boulevard
Rochester, NY
PETER BUSHUNOW, MD
(585) 922-4247
1425 Portland Avenue
Rochester, NY
Paul Gershom Okunieff, MD
585-275-5575
601 Elmwood Ave # 647
Rochester, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Diagnosis of Prostate Cancer Penfield NY
Mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment, a new study contends. Since the PSA screening test came into use in 1986, federal government data show that the number of prostate cancer cases in the United States has risen substantially, said the report in the Aug. 31 online issue of the Journal of the National Cancer Institute.
- Hormone Therapy for Breast Cancer Penfield NY
- Hormone Therapy for Prostate Cancer Penfield NY
- Exercise for Prostate Cancer Penfield NY
- Hormone Therapy for Early Prostate Cancer Penfield NY
- Drug Combo Proves Powerful Against Lung Cancer Penfield NY
- Hormone Therapy for Lung Cancer Penfield NY
- Open Prostatectomy Versus Laparoscopic Procedure Penfield NY
- Head and Neck Cancer Treatment Penfield NY
- Attack Of The Cancer Fighting Tomatoes Penfield NY